Get notified when BIAF files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsbioAffinity Technologies reports record CyPath Lung sales, up nearly 300% year-over-year
Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read
Key Changes
-
high
CyPath Lung diagnostic test achieved record unit sales in April 2026, up nearly 300% compared to April 2025, marking the highest single-month performance for the company's flagship product.
Item 7.01 view on EDGAR → -
medium
Sales figures are preliminary and unaudited, indicating strong commercial momentum but subject to potential revision upon final accounting review.
8-K: Sales disclosure verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.
Partner
Trade BIAF commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 2:42 PM